Oral Genome has partnered with Henry Schein to expand the use of salivary testing in dental and medical offices.
The partnership aims to advance medical-dental integration through point-of-care testing, according to an Aug. 12 news release.
Oral Genome’s test kits analyze key biomarkers in saliva, delivering insight into patients’ oral and overall health in 15 minutes.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
